Effects of Expiratory Positive Airway Pressure on Exercise Tolerance, Dynamic Hyperinflation, and Dyspnea in COPD

References

1. 1.↵
   1. O'Donnell DE,
   2. Laveneziana P,
   3. Webb K,
   4. Neder JA

   . Chronic obstructive pulmonary disease: clinical integrative physiology. Clinics in Chest Medicine 2014;35(1):51–69.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. O'Donnell DE,
   2. Elbehairy AF,
   3. Berton DC,
   4. Domnik ND,
   5. Neder JA

   . Advances in the evaluation of respiratory pathophysiology during exercise in chronic lung diseases. Front Physiol 2017;8:82.

   OpenUrl
3. 3.↵
   1. Langer D,
   2. Ciavaglia CE,
   3. Neder JA,
   4. Webb KA,
   5. O'Donnell DE

   . Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment. Expert Rev Respir Med 2014;8(6):731–749.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Casanova C,
   2. Cote C,
   3. de Torres JP,
   4. Aguirre-Jaime A,
   5. Marin JM,
   6. Pinto-Plata V,
   7. Celli BR

   . Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171(6):591–597.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. O'Donnell DE

   . Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3(2):180–184.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Tzani P,
   2. Aiello M,
   3. Elia D,
   4. Boracchia L,
   5. Marangio E,
   6. Olivieri D,
   7. et al

   . Dynamic hyperinflation is associated with a poor cardiovascular response to exercise in COPD patients. Respir Res 2011;12:150.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Watz H,
   2. Waschki B,
   3. Meyer T,
   4. Kretschmar G,
   5. Kirsten A,
   6. Claussen M,
   7. Magnussen H

   . Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest 2010;138(1):32–38.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Loring SH,
   2. Garcia-Jacques M,
   3. Malhotra A

   . Pulmonary characteristics in COPD and mechanisms of increased work of breathing. J Appl Physiol 2009;107(1):309–314.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Casaburi R,
   2. Porszasz J

   . Reduction of hyperinflation by pharmacologic and other interventions. Proc Am Thorac Soc 2006;3(2):185–189.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Mueller RE,
    2. Petty TL,
    3. Filley GF

    . Ventilation and arterial blood gas changes induced by pursed lips breathing. J Appl Physiol 1970;28(6):784–789.

    OpenUrlFREE Full Text
11. 11.↵
    1. Spahija J,
    2. de Marchie M,
    3. Grassino A

    . Effects of imposed pursed-lips breathing on respiratory mechanics and dyspnea at rest and during exercise in COPD. Chest 2005;128(2):640–650.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. de Araujo CL,
    2. Karloh M,
    3. Dos Reis CM,
    4. Palú M,
    5. Mayer AF

    . Pursed-lips breathing reduces dynamic hyperinflation induced by activities of daily living test in patients with chronic obstructive pulmonary disease: A randomized cross-over study. J Rehabil Med 2015;47(10):957–962.

    OpenUrl
13. 13.↵
    1. Hernandes NA,
    2. Pitta F

    . Use of expiratory positive airway pressure delivered by a spring load resistor during exercise: a new tool to optimize exercise training in patients with COPD? Respir Care 2012;57(9):1530–1531.

    OpenUrlFREE Full Text
14. 14.↵
    1. Padkao T,
    2. Boonsawat W,
    3. Jones CU

    . Conical-PEP is safe, reduces lung hyperinflation and contributes to improved exercise endurance in patients with COPD: a randomised cross-over trial. J Physiother 2010;56(1):33–39.

    OpenUrlPubMed
15. 15.↵
    1. Monteiro MB,
    2. Berton DC,
    3. Moreira MA,
    4. Menna-Barreto SS,
    5. Teixeira PJ

    . Effects of expiratory positive airway pressure on dynamic hyperinflation during exercise in patients with COPD. Respir Care 2012;57(9):1405–1412.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Wibmer T,
    2. Rüdiger S,
    3. Heitner C,
    4. Kropf-Sanchen C,
    5. Blanta I,
    6. Stoiber KM,
    7. et al

    . Effects of nasal positive expiratory pressure on dynamic hyperinflation and 6-minute walk test in patients with COPD. Respir Care 2014;59(5):699–708.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Martin AD,
    2. Davenport PW

    . Extrinsic threshold PEEP reduces post-exercise dyspnea in COPD patients: a placebo-controlled, double-blind cross-over study. Cardiopulm Phys Ther J 2011;22(3):5–10.

    OpenUrlPubMed
18. 18.↵
    1. Nicolini A,
    2. Merliak F,
    3. Barlascini C

    . Use of positive expiratory pressure during six minute walk test: results in patients with moderate to severe chronic obstructive pulmonary disease. Multidiscip Respir Med 2013;8(1):19.

    OpenUrlPubMed
19. 19.↵
    1. Russo D,
    2. Simonelli C,
    3. Paneroni M,
    4. Saleri M,
    5. Piroddi IM,
    6. Cardinale F,
    7. et al

    . Is there an optimal level of positive expiratory pressure (PEP) to improve walking tolerance in patients with severe COPD? Arch Bronconeumol 2016;52(7):354–360.

    OpenUrl
20. 20.↵
    1. van der Schans CP,
    2. de Jong W,
    3. de Vries G,
    4. Kaan WA,
    5. Postma DS,
    6. Koëter GH,
    7. van der Mark TW

    . Effects of positive expiratory pressure breathing during exercise in patients with COPD. Chest 1994;105(3):782–789.

    OpenUrlPubMed
21. 21.↵
    1. Stark-Leyva KN,
    2. Beck KC,
    3. Johnson BD

    . Influence of expiratory loading and hyperinflation on cardiac output during exercise. J Appl Physiol (1985) 2004;96(5):1920–1927.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Goelzer LS,
    2. Medeiros SG,
    3. Giacomini AC,
    4. Mustafa RC,
    5. Müller P de T

    . Effects of EPAP on exercise tolerance in COPD patients with dynamic hyperinflation and suspected abnormal left ventricular filling pressure by echocardiography. Int J Cardiol 2016;203:888–890.

    OpenUrl
23. 23.↵
    1. O'Donnell DE,
    2. Travers J,
    3. Webb KA,
    4. He Z,
    5. Lam YM,
    6. Hamilton A,
    7. et al

    . Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD. Eur Respir J 2009;34(4):866–874.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Guenette JA,
    2. Chin RC,
    3. Cory JM,
    4. Webb KA,
    5. O'Donnell DE

    . Inspiratory capacity during exercise: measurement, analysis, and interpretation. Pulm Med 2013;2013:e956081.

    OpenUrl
25. 25.↵
    1. Holland AE,
    2. Hill CJ,
    3. Rasekaba T,
    4. Lee A,
    5. Naughton MT,
    6. McDonald CF

    . Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2010;91(2):221–225.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    1. Puente-Maestu L,
    2. Palange P,
    3. Casaburi R,
    4. Laveneziana P,
    5. Maltais F,
    6. Neder JA,
    7. et al

    . Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement. Eur Respir J 2016;47(2):429–460.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    1. Vestbo J,
    2. Hurd SS,
    3. Agusti AG,
    4. Jones PW,
    5. Vogelmeier C,
    6. Anzueto A,
    7. et al

    . Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187(4):347–365.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Borg GA

    . Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14(5):377–81.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    1. Guenette JA,
    2. Webb KA,
    3. O'Donnell DE

    . Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? Eur Respir J 2012;40(2):322–329.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Ma Y,
    2. Mazumdar M,
    3. Memtsoudis SG

    . Beyond repeated-measures analysis of variance: advanced statistical methods for the analysis of longitudinal data in anesthesia research. Reg Anesth Pain Med 2012;37(1):99–105.

    OpenUrlCrossRefPubMed
31. 31.↵
    1. Petrof BJ,
    2. Calderini E,
    3. Gottfried SB

    . Effect of CPAP on respiratory effort and dyspnea during exercise in severe COPD. J Appl Physiol 1990;69(1):179–188.

    OpenUrlAbstract/FREE Full Text
32. 32.↵
    1. Papandrinopoulou D,
    2. Tzouda V,
    3. Tsoukalas G

    . Lung compliance and chronic obstructive pulmonary disease. Pulm Med 2012;542769, 2012.

    OpenUrlPubMed
33. 33.↵
    1. Casaburi R,
    2. Rennard SI

    . Exercise limitation in chronic obstructive pulmonary disease. The O'Donnell threshold. Am J Respir Crit Care Med 2015;191(8):873–875.

    OpenUrlCrossRefPubMed
34. 34.↵
    1. Katayama K,
    2. Itoh Y,
    3. Saito M,
    4. Koike T,
    5. Ishida K

    . Sympathetic vasomotor outflow and blood pressure increase during exercise with expiratory resistance. Physiol Rep 2015;3(5).pii:e12421.

    OpenUrlAbstract/FREE Full Text
35. 35.↵
    1. Puente-Maestu L,
    2. Villar F,
    3. de Miguel J,
    4. Stringer WW,
    5. Sanz P,
    6. Sanz ML,
    7. et al

    . Clinical relevance of constant power exercise duration changes in COPD. Eur Respir J 2009;34(2):340–345.

    OpenUrlAbstract/FREE Full Text
36. 36.↵
    1. Whipp BJ,
    2. Ward SA,
    3. Wasserman K

    . Ventilatory responses to exercise and their control in man. Am Rev Respir Dis 1984;129:S17–S20.

    OpenUrlCrossRefPubMedWeb of Science
37. 37.↵
    1. Neder JA,
    2. Jones PW,
    3. Nery LE,
    4. Whipp BJ

    . Determinants of the exercise endurance capacity in patients with chronic obstructive pulmonary disease. The power duration relationship. Am J Respir Crit Care Med 2000;162:497–504.

    OpenUrlCrossRefPubMedWeb of Science
38. 38.↵
    1. Elbehairy AF,
    2. Ciavaglia CE,
    3. Webb KA,
    4. Guenette JA,
    5. Jensen D,
    6. Mourad SM,
    7. et al

    ; on behalf of the Canadian Respiratory Research Network. Pulmonary gas exchange abnormalities in mild chronic obstructive pulmonary disease. Implications for dyspnea and exercise intolerance Am J Respir Crit Care Med 2015;191(12):1384–94.

    OpenUrl